Company Overview
Snapshot
Founded in May 2022 by Yoav Rapaport and Igal Chertkow, PerMe operates with 11–50 employees. The company has raised $2,000,000 across two funding rounds, attracting two investors. In January 2025, PerMe secured a funding round with Rhodium participating.
Business overview
PerMe is a deep-tech digital health platform focused on disruptive innovation in home testing. The company develops a novel IP that converts biological samples into digital information in real-time using an affordable device, eliminating the need for traditional labs. PerMe's software processes biological data to generate health recommendations and facilitate telehealth consultations. By applying advanced data analytics and AI/ML to the collected big data, PerMe aims to drive healthcare innovation, enhance understanding of complex diseases, and accelerate new medicine discovery. The company operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare, Patient Remote Monitoring, and Digital Medical Diagnostics, serving patients and providers.
Strategic signal
In November 2024, PerMe was highlighted by CTech for its revolutionary approach to DNA diagnostics. This recognition underscores the company's potential to significantly impact the digital health and diagnostics market by offering a novel, accessible solution for home DNA testing. The signal to investors is one of strong technological validation and market disruption, indicating PerMe's forward trajectory in transforming how biological data is collected, analyzed, and utilized for health management.
Log in to access full profile ›Company Intelligence Q&A
- When was PerMe founded?
- PerMe was founded in May 2022.
- Who are the founders of PerMe?
- PerMe was founded by Yoav Rapaport and Igal Chertkow.
- What is PerMe's primary sector?
- PerMe's primary sector is Health Tech & Life Sciences.
- What was a significant funding event for PerMe?
- In January 2025, PerMe secured a funding round with participation from Rhodium.
- What is PerMe's core technology?
- PerMe develops a deep-tech digital health platform that converts biological samples to digital information in real-time using a novel IP and an affordable device, leveraging AI/ML for data analytics.